MedicaidPrior AuthHigh impact
c 277221
Pennsylvania Medicaid (DHS)·PA · Pharmacy, Oncology, Dermatology +8 more·Provider Bulletin
Effective date
Jul 23, 2018
We identified it
Jun 20, 2026
Summary
Pennsylvania Medicaid updated its Preferred Drug List (PDL) effective July 23, 2018, adding new drug classes and changing preferred/non-preferred status for numerous medications. Key changes include adding 19 new preferred drugs that require clinical prior authorization, including oncology agents, immunomodulators, and specialty medications.
Action Required
Immediately: Pharmacy and prescribing teams must update systems to reflect new PDL changes effective July 23, 2018. Obtain prior authorization for 19 newly preferred drugs including Alunbrig, Calquence, Erleada, Nucala, Praluent, Xolair, and others listed in section 5. Update prescribing protocols to check www.papdl.com for current preferred status. Failure to obtain required prior authorization will result in claim denials for Pennsylvania Medicaid patients.